International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
Institute for Democratic Alternatives in South Africa was therefore limited despite complaints by society concerning the political climate and the state of democracy in the country. Society's funding of political parties did not seem to be a problem though and the organization would close on 26 March 2013 after a press announcement by Paul Graham, the Executive Director of The Institute for Democracy in Africa. Institute for Democratic Alternatives in South Africa The Institute for Democratic Alternatives in South Africa (IDASA) later known as the Institute for Democracy in South Africa was a South African-based think-tank organisation that was formed in 1986 by Frederik van Zyl Slabbert